1 Department of Orthopaedics, Kantonsspital Baselland, Liestal, Switzerland.
2 Department of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Foot Ankle Int. 2019 Aug;40(8):936-947. doi: 10.1177/1071100719845928. Epub 2019 Apr 25.
In recent years, supramalleolar osteotomy has become a valuable alternative for treatment of ankle osteoarthritis. The aim of this study was to investigate whether the preoperative stage of ankle osteoarthritis or tilt of the talus in the ankle mortise impacts radiologic and clinical outcomes following a supramalleolar osteotomy.
Forty-four patients who underwent a supramalleolar osteotomy for posttraumatic asymmetric varus ankle osteoarthritis were included. Subgroups were formed according to the preoperative stage of ankle osteoarthritis and the tilt of the talus in the ankle mortise. The radiographic and clinical outcomes of each subgroup were compared, and survival rates calculated.
Ankles with a preoperative Takakura stage of 2 and 3a showed a significant higher survival rate at 5 years (88% [95% CI, 67-100] and 93% [95% CI, 80-100]) compared with ankles with a preoperative Takakura stage of 3b (47% [95% CI, 26-86]; = .044). The 5-year survival rate for patients with a preoperative tilt of the talus in the ankle mortise of 4-10 degrees was 85% (95% CI, 68-100), while patients with a preoperative tilt of >10 degrees showed a 5-year survival rate of 65% (95% CI, 46-93; = .117).
Supramalleolar osteotomy was a valuable treatment option for early to mid-stage posttraumatic asymmetric varus ankle osteoarthritis.
Level IV, retrospective cohort study.
近年来,距下骨切开术已成为治疗踝关节骨关节炎的一种有价值的选择。本研究旨在探讨术前踝关节骨关节炎分期或距骨在踝穴中的倾斜是否会影响距下骨切开术后的影像学和临床结果。
纳入 44 例因创伤后不对称内翻踝关节骨关节炎而行距下骨切开术的患者。根据术前踝关节骨关节炎分期和距骨在踝穴中的倾斜将患者分为亚组。比较各亚组的影像学和临床结果,并计算生存率。
术前 Takakura 分期为 2 期和 3a 期的踝关节在 5 年时的生存率明显较高(88%[95%CI,67-100]和 93%[95%CI,80-100]),而术前 Takakura 分期为 3b 期的踝关节生存率为 47%[95%CI,26-86%]( =.044)。术前距骨在踝穴中倾斜 4-10 度的患者 5 年生存率为 85%(95%CI,68-100%),而术前倾斜>10 度的患者 5 年生存率为 65%(95%CI,46-93%)( =.117)。
距下骨切开术是治疗早期至中期创伤后不对称内翻踝关节骨关节炎的一种有价值的治疗选择。
IV 级,回顾性队列研究。